Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
45 studies found for:    "friedreich ataxia"
Show Display Options
RSS Create an RSS feed from your search for:
"friedreich ataxia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Rosuvastatin (Crestor) in Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Rosuvastatin
2 Completed EPI-743 in Friedreich's Ataxia Point Mutations
Condition: Friedreich's Ataxia
Intervention: Drug: EPI-743
3 Completed A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Deferiprone oral solution 100mg/mL;   Drug: Deferiprone oral solution 100 mg/mL
4 Completed A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: placebo;   Drug: deferiprone
5 Recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
6 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
7 Completed Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
Condition: Friedreich's Ataxia
Interventions: Drug: pioglitazone;   Drug: Placebo
8 Completed
Has Results
Interferon Gamma-1b in Friedreich Ataxia (FRDA)
Condition: Friedreich Ataxia
Intervention: Drug: Interferon Gamma-1b
9 Recruiting Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Condition: Friedreich's Ataxia
Intervention:
10 Completed
Has Results
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
11 Completed
Has Results
Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Idebenone;   Drug: Placebo
12 Completed Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
13 Completed A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
14 Completed Safety Study of Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
15 Completed Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling
Condition: Friedreich Ataxia
Intervention:
16 Completed Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
17 Completed
Has Results
Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
Condition: Friedreich's Ataxia
Interventions: Drug: Idebenone;   Drug: Placebo
18 Completed Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Lu AA24493;   Drug: Placebo
19 Completed Iron-Chelating Therapy and Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Iron chelating intervention
20 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: Omaveloxolone Capsules, 2.5 mg;   Drug: Omaveloxolone Capsules, 5 mg;   Drug: Omaveloxolone Capsules, 10 mg;   Drug: Placebo;   Drug: Omaveloxolone Capsules, 20 mg;   Drug: Omaveloxolone Capsules, TBD mg;   Drug: Omaveloxolone Capsules, 40 mg;   Drug: Omaveloxolone Capsules, 80 mg;   Drug: Omaveloxolone Capsules, 160 mg;   Drug: Omaveloxolone Capsules, 300 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.